Stocks
Avantor, Inc.AVTR
NYSEHealthcareMedical Distribution$7.93+0.38%
A global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, Avantor supplies everything from biopharma production materials to lab equipment. The company is closely watched by investors for its exposure to high-growth areas like bioprocessing and diagnostics. Its performance often serves as a bellwether for R&D spending trends across pharmaceuticals and tech sectors.
Market Cap: $5.4B52W Range: $7.82 – $17.11
Congressional Interest in Avantor, Inc. (AVTR)
7 members of Congress have disclosed 40 trades in Avantor, Inc. (AVTR), a Healthcare company. The buy/sell breakdown shows 15 purchases versus 25 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
40
Unique Politicians
7
Buys
15
Sells
25
Who in Congress Is Trading AVTR?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-08-13 | Gilbert Cisneros | sell | $1K – $15K |
| 2025-08-12 | Gilbert Cisneros | sell | $1K – $15K |